SG Americas Securities’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Other funds holding SRNE
PP
OCM
OFA
CGA
LCM
STB
GA
HFRG
VFA
GBWM
SG Americas Securities's SRNE Position: Q1 2023 in Review
SG Americas Securities sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 94,796 shares — an estimated $84K sold.
SG Americas Securities first reported a position in SRNE in Q2 2018 and held it in 14 quarters. The position peaked at $1.46M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.
- SG Americas Securities reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
- SG Americas Securities sold 94,796 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $84K.
- SG Americas Securities first reported a position in Sorrento Therapeutics, Inc. in Q2 2018 and held it in 14 quarters.
- SG Americas Securities's Sorrento Therapeutics, Inc. position peaked at $1.46M in Q3 2020.
- 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.
Based on SG Americas Securities's 13F filing for Q1 2023, filed 28 Apr 2023.